Neural Regeneration Research ›› 2023, Vol. 18 ›› Issue (8): 1703-1704.doi: 10.4103/1673-5374.361668

Previous Articles     Next Articles

Overcoming axon regeneration failure and psychopathology: how may gabapentinoids help boost CNS repair?

Haven I. Rodocker, Andrea Tedeschi*   

  1. Department of Neuroscience, Wexner Medical Center, The Ohio State University, Columbus, OH, USA (Rodocker HI, Tedeschi A)
    Chronic Brain Injury Program, The Ohio State University, Columbus, OH, USA (Tedeschi A)
  • Online:2023-08-15 Published:2023-02-16
  • Contact: Andrea Tedeschi, andrea.tedeschi@osumc.edu.
  • Supported by:
    We would like to thank Dr. Wenjing Sun (The Ohio State University, Wexner Medical Center) for critically reading. Research in the Tedeschi laboratory was supported by the National Institute of Neurological Disorders (R01NS110681 and R21NS109787 (to AT)), the Chronic Brain Injury Program (to AT), and The Ohio State University/Wexner Medical Center. We apologize to all colleagues whose relevant work was not included due to space limitations.

PDF

69

Abstract: Spinal cord injury (SCI) at the cervical level compromises the function of both upper and lower extremities, thereby impeding an individual’s ability to complete daily tasks required for independent living and profoundly affecting the overall quality of life among individuals afflicted by SCI and their families. Recovery of spinal cord functions may be attained by promoting the sprouting of non-injured axons and/or the regeneration of damaged axons. The regenerative capacity of neurons differs profoundly between animal lineages and within the mammalian central and peripheral nervous systems (Tedeschi et al., 2017). Whereas axons in the peripheral nervous system are able to mount a successful regenerative response after injury, long-distance axon regeneration fails in the adult mammalian central nervous system. To date, no therapeutic strategy that aims to restore function is currently available for SCI individuals.